Skip to main content

Peer Review reports

From: E2F2(E2F transcription factor 2) as a potential therapeutic target in meibomian gland carcinoma: evidence from functional and epigenetic studies

Original Submission
11 Nov 2024 Submitted Original manuscript
12 Nov 2024 Author responded Author comments - Tingting Lin
15 Nov 2024 Author responded Author comments - Tingting Lin
Resubmission - Version 2
12 Nov 2024 Submitted Manuscript version 2
15 Nov 2024 Author responded Author comments - Tingting Lin
Resubmission - Version 3
15 Nov 2024 Submitted Manuscript version 3
27 Jan 2025 Reviewed Reviewer Report
5 Feb 2025 Reviewed Reviewer Report
21 Feb 2025 Author responded Author comments - Tingting Lin
Resubmission - Version 4
21 Feb 2025 Submitted Manuscript version 4
Publishing
27 Feb 2025 Editorially accepted
16 May 2025 Article published 10.1186/s12885-025-13833-6

You can find further information about peer review here.

Back to article page